Literature DB >> 16542369

Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.

Y Kanaya1, S Ohga, K Ikeda, K Furuno, T Ohno, H Takada, N Kinukawa, T Hara.   

Abstract

Chromosome 22q11.2 deletion syndrome is a common disorder characterized by thymic hypoplasia, conotruncal cardiac defect and hypoparathyroidism. Patients have a risk of infections and autoimmunity associated with T lymphocytopenia. To assess the immunological constitution of patients, the numerical changes and cytokine profile of circulating T cells were analysed by flow cytometry and real-time polymerase chain reaction (PCR). CD3+, CD4+, T cell receptor (TCR)alphabeta+ or CD8alphaalpha+ cell counts were lower, and CD56+ cell counts were higher in patients than in controls during the period from birth to adulthood. The ageing decline of CD3+ or CD4+ cell counts was slower in patients than in controls. The proportion of CD8alphaalpha+ cells increased in controls, and the slope index was larger than in patients. On the other hand, both the number and proportion of Valpha24+ cells increased in patients, and the slope indexes tended to be larger than in controls. The positive correlation of the number of T cells with CD8alphaalpha+ cells was observed only in patients, and that with Valpha24+ cells was seen only in controls. No gene expression levels of interferon (IFN)-gamma, interleukin (IL)-10, transforming growth factor (TGF)-beta, cytotoxic T lymphocyte antigen 4 (CTLA4) or forkhead box p3 (Foxp3) in T cells differed between patients and controls. There was no significant association between the lymphocyte subsets or gene expression levels and clinical phenotype including the types of cardiac disease, hypocalcaemia and frequency of infection. These results indicated that T-lymphocytopenia in 22q11.2 deletion patients became less severe with age under the altered composition of minor subsets. The balanced cytokine profile in the limited T cell pool may represent a T cell homeostasis in thymic deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542369      PMCID: PMC1809624          DOI: 10.1111/j.1365-2249.2006.03038.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians.

Authors:  Katy Argentati; Francesca Re; Alessia Donnini; Maria G Tucci; Claudio Franceschi; Beatrice Bartozzi; Giovanni Bernardini; Mauro Provinciali
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

2.  Long-term assessment of T-cell populations in DiGeorge syndrome.

Authors:  Javier Chinen; Howard M Rosenblatt; E O'Brian Smith; William T Shearer; Lenora M Noroski
Journal:  J Allergy Clin Immunol       Date:  2003-03       Impact factor: 10.793

3.  Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome.

Authors:  Scott Lawrence; Donna M McDonald-McGinn; Elaine Zackai; Kathleen E Sullivan
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

4.  A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population.

Authors:  Lorenzo D Botto; Kristin May; Paul M Fernhoff; Adolfo Correa; Karlene Coleman; Sonja A Rasmussen; Robert K Merritt; Leslie A O'Leary; Lee-Yang Wong; E Marsha Elixson; William T Mahle; Robert M Campbell
Journal:  Pediatrics       Date:  2003-07       Impact factor: 7.124

5.  CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia.

Authors:  Kathleen E Sullivan; Donna McDonald-McGinn; Elaine H Zackai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

6.  Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells.

Authors:  Shouichi Ohga; Akihiko Nomura; Kenji Ihara; Yasushi Takahata; Naohiro Suga; Hideki Akeda; Rumiko Shibata; Jun Okamura; Naoko Kinukawa; Toshiro Hara
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

7.  CD8alpha alpha memory effector T cells descend directly from clonally expanded CD8alpha +beta high TCRalpha beta T cells in vivo.

Authors:  Akihiro Konno; Kanae Okada; Kazunori Mizuno; Mika Nishida; Shuya Nagaoki; Tomoko Toma; Takahiro Uehara; Kazuhide Ohta; Yoshihito Kasahara; Hidetoshi Seki; Akihiro Yachie; Shoichi Koizumi
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

8.  T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome.

Authors:  Lisa M Piliero; Amy N Sanford; Donna M McDonald-McGinn; Elaine H Zackai; Kathleen E Sullivan
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

9.  Post-natal ontogenesis of the T-cell receptor CD4 and CD8 Vbeta repertoire and immune function in children with DiGeorge syndrome.

Authors:  Caterina Cancrini; Maria Luisa Romiti; Andrea Finocchi; Silvia Di Cesare; Patrizia Ciaffi; Claudia Capponi; Savita Pahwa; Paolo Rossi
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.542

10.  Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  M Pierdominici; F Mazzetta; E Caprini; M Marziali; M C Digilio; B Marino; A Aiuti; F Amati; G Russo; G Novelli; F Pandolfi; G Luzi; A Giovannetti
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

View more
  10 in total

1.  Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1.

Authors:  Serkan Belkaya; Sean E Murray; Jennifer L Eitson; M Teresa de la Morena; James A Forman; Nicolai S C van Oers
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

2.  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  R Zemble; E Luning Prak; K McDonald; D McDonald-McGinn; E Zackai; K Sullivan
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

3.  A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?

Authors:  Elfi Vergaelen; Carmen Schiweck; Kristof Van Steeland; Jacqueline Counotte; Wim Veling; Ann Swillen; Hemmo Drexhage; Stephan Claes
Journal:  Brain Behav Immun       Date:  2018-03-19       Impact factor: 7.217

4.  Downregulation of miR-185 is a common pathogenic event in 22q11.2 deletion syndrome-related and idiopathic schizophrenia.

Authors:  Hani Sabaie; Jalal Gharesouran; Mohammad Reza Asadi; Sara Farhang; Noora Karim Ahangar; Serge Brand; Shahram Arsang-Jang; Saba Dastar; Mohammad Taheri; Maryam Rezazadeh
Journal:  Metab Brain Dis       Date:  2022-01-25       Impact factor: 3.584

5.  Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.

Authors:  P Eberle; C Berger; S Junge; S Dougoud; E Valsangiacomo Büchel; M Riegel; A Schinzel; R Seger; T Güngör
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

Review 6.  Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.

Authors:  Blaine Crowley; Melanie Ruffner; Donna M McDonald McGinn; Kathleen E Sullivan
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

7.  Human FOXN1-deficiency is associated with αβ double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation.

Authors:  Adriana S Albuquerque; José G Marques; Susana L Silva; Dario Ligeiro; Blythe H Devlin; Jacques Dutrieux; Rémi Cheynier; Claudio Pignata; Rui M M Victorino; M Louise Markert; Ana E Sousa
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

8.  Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome.

Authors:  Nico J M van Beveren; Lianne C Krab; Sigrid Swagemakers; Gabriella Buitendijk; Gabriëlle H S Buitendijk; Erik Boot; Peter van der Spek; Ype Elgersma; Therese A M J van Amelsvoort
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

Review 9.  Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models.

Authors:  Pratibha Bhalla; Christian A Wysocki; Nicolai S C van Oers
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

10.  Clinical Phenotype of DiGeorge Syndrome with Negative Genetic Tests: A Case of DiGeorge-Like Syndrome?

Authors:  Gianluigi Laccetta; Benedetta Toschi; Antonella Fogli; Veronica Bertini; Angelo Valetto; Rita Consolini
Journal:  Case Rep Pediatr       Date:  2015-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.